A39.81 Meningococcal encephalitis

Name of the Condition

• Meningococcal encephalitis

Summary

Meningococcal encephalitis is a rare but serious bacterial infection caused by Neisseria meningitidis that results in inflammation of the brain tissue (encephalitis) alongside or distinct from meningitis. This condition involves the central nervous system and may present with neurological symptoms, requiring prompt medical evaluation and treatment to mitigate complications.

Causes

Meningococcal encephalitis is caused by the bacterium Neisseria meningitidis. The bacteria typically enter the body through respiratory droplets or direct contact with infected secretions. Once established, they can invade the bloodstream and cross the blood-brain barrier, leading to inflammation of the brain parenchyma.

Risk Factors

• Close or prolonged contact with an infected individual (e.g., household members, roommates).
• Living in crowded settings (e.g., dormitories, military barracks).
• Travel to regions with high rates of meningococcal disease.
• Lack of vaccination against meningococcal disease.
• Certain medical conditions (e.g., complement deficiencies, asplenia).

Symptoms

• Sudden high fever.
• Severe headache.
• Stiff neck.
• Nausea and vomiting.
• Sensitivity to light (photophobia).
• Confusion or altered mental status.
• Skin rash (may appear as small, dark red or purple spots).
• Seizures or focal neurological deficits (e.g., weakness, speech difficulties).

Diagnosis

Diagnosis involves clinical evaluation and laboratory testing. A lumbar puncture (spinal tap) is performed to analyze cerebrospinal fluid for bacterial presence, cell count, and biochemical markers. Blood cultures, imaging (e.g., MRI or CT), and PCR testing may also be used to confirm infection and assess brain involvement.

Treatment Options

Treatment typically includes intravenous antibiotics (e.g., ceftriaxone or penicillin) to target Neisseria meningitidis. Supportive care, such as managing fever, seizures, or intracranial pressure, may be necessary. Corticosteroids are sometimes used to reduce inflammation, and close monitoring in a hospital setting is critical.

Prognosis and Follow-Up

Prognosis depends on the severity of infection and timeliness of treatment. Early intervention improves outcomes, but neurological sequelae (e.g., cognitive impairment, motor deficits) may occur. Follow-up includes monitoring for complications and rehabilitation as needed.

Complications

• Neurological damage (e.g., seizures, cognitive impairment).
• Hearing loss or vision problems.
• Septic shock or multi-organ failure.
• Long-term disability or death (in severe cases).

Lifestyle & Prevention

• Vaccination against meningococcal disease is the most effective preventive measure.
• Avoid close contact with infected individuals during outbreaks.
• Practice good hygiene (e.g., handwashing) to reduce transmission risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as sudden high fever, severe headache, stiff neck, confusion, or rash develop, as these may indicate meningococcal encephalitis.

Tips for Medical Coders

Document the presence of encephalitis (brain inflammation) alongside meningitis when coding for A39.81. Ensure clinical notes specify neurological symptoms or diagnostic findings (e.g., MRI results) to support the diagnosis. Differentiate from other meningococcal infections (e.g., meningitis alone) based on documented involvement of brain tissue.